Gordon, M. S., Mendelson, D. S., Gross, M., Uttenreuther-Fischer, M., Ould-Kaci, M., Zhao, Y., . . . Agus, D. B. (2012). A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors. Springer US.
Citação norma ChicagoGordon, Michael S., David S. Mendelson, Mitchell Gross, Martina Uttenreuther-Fischer, Mahmoud Ould-Kaci, Yihua Zhao, Peter Stopfer, and David B. Agus. A Phase I, Open-label, Dose-escalation Study of Continuous Once-daily Oral Treatment With Afatinib in Patients With Advanced Solid Tumors. Springer US, 2012.
Citação norma MLAGordon, Michael S., et al. A Phase I, Open-label, Dose-escalation Study of Continuous Once-daily Oral Treatment With Afatinib in Patients With Advanced Solid Tumors. Springer US, 2012.